• Something wrong with this record ?

Focal histopathological progression of porcine experimental abdominal aortic aneurysm is mitigated by atorvastatin

K. Houdek, J. Moláček, V. Třeška, V. Křížková, L. Eberlová, L. Boudová, L. Nedorost, P. Tolinger, J. Kočová, J. Kobr, J. Baxa, V. Liška, K. Witter, Z. Tonar,

. 2013 ; 32 (3) : 291-306.

Language English Country Italy

Document type Journal Article, Research Support, Non-U.S. Gov't

AIM: Observational studies in human patients and animal experiments suggested that statins have a potential in slowing the growth of small abdominal aortic aneurysms (AAA). Our aim was to quantify histological postoperative changes of AAA in porcine experimental model of AAA with and without administration of atorvastatin. METHODS: The AAA was induced by intraaortic infusion of porcine pancreatic elastase and subrenal application of plastic cuff. The AAA statin group (N.=14) received atorvastatin 1 mg/kg daily for 28 days, the other AAA group (N.=13) did not. The aortic diameter was measured by ultrasonography. Aortic samples were described using eleven quantitative histological parameters and compared with healthy aortae. RESULTS: There was no difference in aortic diameter between the AAA with statin when compared to AAA without statin. Administration of atorvastatin led to a better postoperative histological condition of the aortic elastin network, preservation of contractile phenotype of vascular smooth muscle, a higher density of vasa vasorum, it prevented thickening of intima and media. The increase in wall thickness in AAA without atorvastatin has not been accompanied by a proportional increase in number of vasa vasorum. CONCLUSION: The effects of atorvastatin seem to prevent the histopathological progression of AAA.

000      
00000naa a2200000 a 4500
001      
bmc14051046
003      
CZ-PrNML
005      
20171018135236.0
007      
ta
008      
140401s2013 it f 000 0|eng||
009      
AR
035    __
$a (PubMed)23711681
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a it
100    1_
$a Houdek, K
245    10
$a Focal histopathological progression of porcine experimental abdominal aortic aneurysm is mitigated by atorvastatin / $c K. Houdek, J. Moláček, V. Třeška, V. Křížková, L. Eberlová, L. Boudová, L. Nedorost, P. Tolinger, J. Kočová, J. Kobr, J. Baxa, V. Liška, K. Witter, Z. Tonar,
520    9_
$a AIM: Observational studies in human patients and animal experiments suggested that statins have a potential in slowing the growth of small abdominal aortic aneurysms (AAA). Our aim was to quantify histological postoperative changes of AAA in porcine experimental model of AAA with and without administration of atorvastatin. METHODS: The AAA was induced by intraaortic infusion of porcine pancreatic elastase and subrenal application of plastic cuff. The AAA statin group (N.=14) received atorvastatin 1 mg/kg daily for 28 days, the other AAA group (N.=13) did not. The aortic diameter was measured by ultrasonography. Aortic samples were described using eleven quantitative histological parameters and compared with healthy aortae. RESULTS: There was no difference in aortic diameter between the AAA with statin when compared to AAA without statin. Administration of atorvastatin led to a better postoperative histological condition of the aortic elastin network, preservation of contractile phenotype of vascular smooth muscle, a higher density of vasa vasorum, it prevented thickening of intima and media. The increase in wall thickness in AAA without atorvastatin has not been accompanied by a proportional increase in number of vasa vasorum. CONCLUSION: The effects of atorvastatin seem to prevent the histopathological progression of AAA.
650    _2
$a zvířata $7 D000818
650    _2
$a aorta abdominalis $x účinky léků $x patologie $x ultrasonografie $7 D001012
650    _2
$a aneurysma břišní aorty $x chemicky indukované $x patologie $x prevence a kontrola $x ultrasonografie $7 D017544
650    _2
$a modely nemocí na zvířatech $7 D004195
650    _2
$a progrese nemoci $7 D018450
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a kyseliny heptylové $x farmakologie $7 D006538
650    _2
$a statiny $x farmakologie $7 D019161
650    _2
$a pankreatická elastasa $7 D010196
650    _2
$a pyrroly $x farmakologie $7 D011758
650    _2
$a Sus scrofa $7 D034421
650    _2
$a časové faktory $7 D013997
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Moláček, J $u -
700    1_
$a Třeška, V $u -
700    1_
$a Křížková, V $u -
700    1_
$a Eberlová, L $u -
700    1_
$a Boudová, L $u -
700    1_
$a Nedorost, L $u -
700    1_
$a Tolinger, P $u -
700    1_
$a Kočová, J $u -
700    1_
$a Kobr, J $u -
700    1_
$a Baxa, J $u -
700    1_
$a Liška, V $u -
700    1_
$a Witter, K $u -
700    1_
$a Tonar, Zbyněk, $d 1976- $7 xx0074224
773    0_
$w MED00002267 $t International angiology a journal of the International Union of Angiology $x 1827-1839 $g Roč. 32, č. 3 (2013), s. 291-306
856    41
$u https://pubmed.ncbi.nlm.nih.gov/23711681 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20140401 $b ABA008
991    __
$a 20171018135309 $b ABA008
999    __
$a ok $b bmc $g 1018182 $s 849626
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2013 $b 32 $c 3 $d 291-306 $i 1827-1839 $m International angiology $n Int Angiol $x MED00002267
LZP    __
$a Pubmed-20140401

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...